Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Q Huang

Showing results (1-10 of 221) with videos related to

Pageof 23
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|February 21, 2020
Hepatitis B: Who to treat? A critical review of international guidelinesDaniel Q Huang, Seng Gee Lim
Alimentary Pharmacology & Therapeutics|November 9, 2022
Review article: the role of HSD17B13 on global epidemiology, natural history, pathogenesis and treatment of NAFLDMaral Amangurbanova, Daniel Q Huang, Rohit Loomba
Nature Reviews. Gastroenterology & Hepatology|December 22, 2020
Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and preventionDaniel Q Huang, Hashem B El-Serag, Rohit Loomba
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 30, 2022
Noninvasive assessment of liver fibrosis and its clinical significance in nonalcoholic fatty liver diseaseNobuharu Tamaki, Masayuki Kurosaki, Daniel Q Huang, et al.
Nature Reviews. Gastroenterology & Hepatology|April 6, 2023
Global burden of hepatitis B virus: current status, missed opportunities and a call for actionYao-Chun Hsu, Daniel Q Huang, Mindie H Nguyen
Clinical and Molecular Hepatology|May 11, 2022
Nonalcoholic fatty liver disease versus metabolic-associated fatty liver disease: Prevalence, outcomes and implications of a change in nameCheng Han Ng, Daniel Q Huang, Mindie H Nguyen
Clinics in Liver Disease|October 1, 2021
Controversies in Treating Chronic Hepatitis B virus: The Role of Hepatitis B Virus DNA and Surface Antigen TiterDaniel Q Huang, Guan Sen Kew, Seng Gee Lim
Nature Reviews. Gastroenterology & Hepatology|October 18, 2022
Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factorsDaniel Q Huang, Philippe Mathurin, Helena Cortez-Pinto, et al.
Clinical and Translational Medicine|July 31, 2025
Developing risk stratification strategies and biomarkers for recurrent hepatocellular carcinomaJia-Hao Law, Huilin Shao, Ramanuj DasGupta, et al.
Alimentary Pharmacology & Therapeutics|March 2, 2022
Review article: current and emerging therapies for the management of cirrhosis and its complicationsElliot B Tapper, Nneka N Ufere, Daniel Q Huang, et al.
Pageof 23

Showing results (1-10 of 221) with videos related to

Sort By:
Pageof 23
Liver International : Official Journal of the International Association for the Study of the Liver|February 21, 2020
Hepatitis B: Who to treat? A critical review of international guidelinesDaniel Q Huang, Seng Gee Lim
Alimentary Pharmacology & Therapeutics|November 9, 2022
Review article: the role of HSD17B13 on global epidemiology, natural history, pathogenesis and treatment of NAFLDMaral Amangurbanova, Daniel Q Huang, Rohit Loomba
Nature Reviews. Gastroenterology & Hepatology|December 22, 2020
Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and preventionDaniel Q Huang, Hashem B El-Serag, Rohit Loomba
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 30, 2022
Noninvasive assessment of liver fibrosis and its clinical significance in nonalcoholic fatty liver diseaseNobuharu Tamaki, Masayuki Kurosaki, Daniel Q Huang, et al.
Nature Reviews. Gastroenterology & Hepatology|April 6, 2023
Global burden of hepatitis B virus: current status, missed opportunities and a call for actionYao-Chun Hsu, Daniel Q Huang, Mindie H Nguyen
Clinical and Molecular Hepatology|May 11, 2022
Nonalcoholic fatty liver disease versus metabolic-associated fatty liver disease: Prevalence, outcomes and implications of a change in nameCheng Han Ng, Daniel Q Huang, Mindie H Nguyen
Clinics in Liver Disease|October 1, 2021
Controversies in Treating Chronic Hepatitis B virus: The Role of Hepatitis B Virus DNA and Surface Antigen TiterDaniel Q Huang, Guan Sen Kew, Seng Gee Lim
Nature Reviews. Gastroenterology & Hepatology|October 18, 2022
Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factorsDaniel Q Huang, Philippe Mathurin, Helena Cortez-Pinto, et al.
Clinical and Translational Medicine|July 31, 2025
Developing risk stratification strategies and biomarkers for recurrent hepatocellular carcinomaJia-Hao Law, Huilin Shao, Ramanuj DasGupta, et al.
Alimentary Pharmacology & Therapeutics|March 2, 2022
Review article: current and emerging therapies for the management of cirrhosis and its complicationsElliot B Tapper, Nneka N Ufere, Daniel Q Huang, et al.
Pageof 23